10 studies found for:    "methodist hospital" | Open Studies | "Constriction, Pathologic" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Condition: Carotid Stenosis
Interventions: Procedure: Carotid endarterectomy;   Device: Carotid stenting
2 Recruiting ABSORB III Randomized Controlled Trial (RCT)
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
3 Recruiting PERIGON Pivotal Trial
Condition: Aortic Stenosis
Intervention: Device: Model 400 aortic valve bioprosthesis
4 Recruiting Absorb IV Randomized Controlled Trial
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
5 Recruiting The Medtronic TAVR 2.0 US Clinical Study
Condition: Aortic Valve Stenosis
Intervention: Device: Medtronic Transcatheter Aortic Valve 2.0 Replacement System
6 Recruiting The PARTNER II Trial: S3iCAP
Condition: Aortic Stenosis
Intervention: Device: TAVR with SAPIEN S3 valve
7 Recruiting Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Condition: Aortic Valve Stenosis
Interventions: Device: Portico transcatheter aortic valve;   Device: Commercially available transcatheter aortic valve
8 Recruiting A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Conditions: Coronary Disease;   Coronary Stenosis
Interventions: Procedure: FFR guided PCI;   Procedure: CABG
9 Recruiting Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Condition: Severe Aortic Stenosis
Interventions: Device: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI);   Procedure: Surgical Aortic Valve Replacement (SAVR);   Device: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)
10 Recruiting Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Eleclazine;   Drug: Placebo

Indicates status has not been verified in more than two years